Skip to main content
OpenTrials

Clinical trial condition

Dermatitis

Explore clinical trials studying Dermatitis. Study availability and eligibility vary by location and protocol.

1,525 public trials 180 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis trial results

Completed

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

NCT04445987

Conditions
Dermatitis, Dermatitis, Seborrheic, Sebaceous Gland Diseases, +5 more
Locations
  • Arcutis Biotherapeutics Clinical Site 59 Beverly Hills, California, United States
  • Arcutis Biotherapeutics Clinical Site 51 Encino, California, United States
  • Arcutis Biotherapeutics Clinical Site 75 Fountain Valley, California, United States
  • Arcutis Biotherapeutics Clinical Site 19 Fremont, California, United States
View all 39 locations
View Trial Details
Completed

Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis

NCT02004041

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +13 more
Locations
  • Vanda Investigational Site Düsseldorf, Germany
  • Vanda Investigational Site Hamburg, Germany
  • Vanda Investigational Site Jena, Germany
  • Vanda Investigational Site Kiel, Germany
View Trial Details
Completed

Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis

NCT05117060

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • LEO Pharma Investigational Site Beverly Hills, California, United States
  • LEO Pharma Investigational Site Los Angeles, California, United States
  • LEO Pharma Investigational Site San Diego, California, United States
  • LEO Pharma Investigational Site Cincinnati, Ohio, United States
View all 45 locations
View Trial Details
Completed

A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable

NCT03428100

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Universitätsklinikum Graz Graz, Styria, Austria
  • Universitätsklinik Innsbruck Innsbruck, Tyrol, Austria
  • KA Rudolfstiftung Vienna, Austria
  • AKH Vienna, Austria
View all 103 locations
View Trial Details
Completed

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

NCT03568331

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Vanda Investigational Site Birmingham, Alabama, United States
  • Vanda Investigational Site Birmingham, Alabama, United States
  • Vanda Investigational Site Tempe, Arizona, United States
  • Vanda Investigational Site Encino, California, United States
View all 70 locations
View Trial Details
Completed

Skin Pathology Assessment With Optical Technologies

NCT04295824

Conditions
Atopic Dermatitis Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Sheffield Dermatology Research, University of Sheffield Medical School, The Royal Hallamshire Hospital Sheffield, South Yorkshire, United Kingdom
View Trial Details

Related conditions